Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.

Employees

144

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
01/10/26	KRW 4,570.00	+2.93%	108,080
30/09/26	KRW 4,440.00	+1.02%	87,788
29/09/26	KRW 4,395.00	-4.35%	121,887
28/09/26	KRW 4,595.00	+0.66%	96,979
23/09/26	KRW 4,565.00	+1.44%	134,603

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 01/10/2026			5-day change	1st Jan Change
4,570.00 ^KRW	+2.93%		+0.11%	-25.57%

14/08	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	69.87B 51.27M 45.53M 42.58M 38.8M 73.05M 4.94B 74.06M 515M 199M 2.51B 192M 188M 8.07B	P/E 2024	-5.35x	P/E 2025	-4.03x
Enterprise Value	39.67B 29.11M 25.85M 24.18M 22.03M 41.48M 2.8B 42.05M 292M 113M 1.43B 109M 107M 4.58B	EV / Sales 2024	3.27x	EV / Sales 2025	6.76x
Free-Float	76.84%	Yield 2024 *	-	Yield 2025	-

14/08	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
18/03	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/11	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
29/08/25	Sugentech to divest 12.5 billion won worth of own shares	RE
29/08/25	Sugentech Inc. announced that it expects to receive KRW 12.506195 billion in funding from Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund, IBK Capital Corporation, Korea Investment & Securities Co., Ltd. and other investors	CI
14/08/25	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
11/03/25	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11/03/25	Sugentech Inc. Auditor Raises 'Going Concern' Doubt	CI
14/11/24	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
23/09/24	Sugentech Inc.(KOSDAQ:A253840) dropped from S&P Global BMI Index	CI
28/12/23	Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023.	CI

1 day	+2.93%
1 week	+0.11%
Current month	+2.93%
1 month	+2.81%
3 months	+19.63%
6 months	-0.98%
Current year	-25.57%

Sugentech Inc. Stock

Stocks

A253840

KR7253840003

Medical Equipment, Supplies & Distribution

Valuation: Sugentech Inc.

Chart: Sugentech Inc.

Latest news: Sugentech Inc.

Press Releases: Sugentech Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Sugentech Inc.

Latest insider transactions

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 week	4,350	4,650
1 month	4,205	4,810
Current year	3,530	8,170
1 year	3,530	8,250
3 years	3,530	11,500
5 years	3,530	23,750
10 years	3,530	65,800

Manager	Title	Age	Since
Seong-Bum Yoo CTO	Chief Tech/Sci/R&D Officer	59	26/09/2017
Mi-Jin Sohn CEO	Chief Executive Officer	61	26/09/2017
Hae-Gwon Lee DFI	Director of Finance/CFO	56	31/03/2022

Director	Title	Age	Since
Mi-Jin Sohn BRD	Director/Board Member	61	26/09/2017
Seong-Bum Yoo BRD	Director/Board Member	59	26/09/2017
Jae-Hong Jeon BRD	Director/Board Member	51	31/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUGENTECH INC.	+2.93%	+0.11%	-32.70%	-36.26%	50.12M
ABBOTT LABORATORIES	-1.41%	-3.66%	-27.05%	+1.71%	171B
MEDTRONIC PLC	+0.28%	-2.23%	-8.72%	+11.28%	110B
STRYKER CORPORATION	-0.75%	+1.19%	-25.04%	-0.32%	106B
ESSILORLUXOTTICA	-0.69%	-0.07%	-47.78%	-11.65%	75.99B
CENCORA, INC.	+2.85%	-0.43%	-1.04%	+72.29%	57.3B
BECTON, DICKINSON AND COMPANY	-0.31%	-0.59%	-6.69%	-30.88%	48.76B
HOYA CORPORATION	+3.44%	+7.90%	+19.12%	+59.15%	50.19B
IDEXX LABORATORIES, INC.	-0.35%	+1.61%	-15.88%	+21.05%	41.14B
DEXCOM, INC.	+0.03%	-1.29%	+30.67%	-8.68%	32.56B
Average	+0.61%	-1.30%	-11.51%	+7.77%	69.3B
Weighted average by Cap.	-0.04%	-2.07%	-15.80%	+9.82%

	2024	2025
Net sales	10.1B 7.41M 6.58M 6.15M 5.61M 10.56M 713M 10.7M 74.44M 28.82M 363M 27.81M 27.21M 1.17B	9.42B 6.91M 6.14M 5.74M 5.23M 9.85M 665M 9.98M 69.43M 26.88M 339M 25.94M 25.38M 1.09B
Net income	-15.19B -11.15M -9.9M -9.26M -8.44M -15.88M -1.07B -16.1M -112M -43.36M -547M -41.85M -40.94M -1.76B	-23.31B -17.11M -15.19M -14.21M -12.95M -24.38M -1.65B -24.71M -172M -66.54M -839M -64.22M -62.83M -2.69B
Net Debt	-48.51B -35.59M -31.61M -29.56M -26.94M -50.71M -3.43B -51.41M -358M -138M -1.75B -134M -131M -5.61B	-30.2B -22.16M -19.68M -18.41M -16.77M -31.58M -2.13B -32.01M -223M -86.2M -1.09B -83.2M -81.39M -3.49B